Breakthrough Genomics collaborates with healthcare providers, research institutions, and organizations worldwide to provide accurate genetic tests with fast turnaround times. Utilizing Next-Generation Sequencing (NGS) assay technology, Breakthrough Genomics has recently developed a groundbreaking method for early detection screening of pancreatic cancer. Breakthrough Genomics aims to revolutionize genomic medicine with their advanced technology and clinical expertise.
Text
Cancel OK